Related Experiment Video
Updated: Jul 28, 2026

In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
Published on: November 10, 2011
Intracellular degradation by liver endothelial cells
S Misquith1, S Wattiaux-De Coninck, R Wattiaux
1Laboratoire de Chimie Physiologique, Facultés Universitaires Notre Dame de la Paix, Namur, Belgium.
This study explored how liver non-parenchymal cells break down formaldehyde-treated bovine serum albumin (F-BSA). Using both in vivo and in vitro methods, the researchers found that degradation occurs in two steps. The first step likely happens in a hybrid endosome-lysosome structure, while the second step occurs in transfer lysosomes. Endosomes themselves were not involved in degradation, and accumulation lysosomes lacked efficient proteolytic activity. The findings suggest a compartmentalized degradation pathway in liver endothelial cells, with distinct organelles handling each stage of the process.
Area of Science:
- Cell biology of endocytic pathways
- Liver physiology and metabolism
- Protein degradation mechanisms
Background:
The intracellular degradation of exogenous proteins remains poorly understood in liver non-parenchymal cells. Prior research has shown that endocytic pathways involve multiple organelles, including endosomes and lysosomes. However, the specific roles of these compartments in protein breakdown are not fully resolved. Some studies suggest that lysosomes are central to degradation, but the sequence and compartmentalization of this process remain unclear. No prior work had resolved whether distinct lysosomal subtypes handle different stages of degradation. This gap motivated the investigation of formaldehyde-treated bovine serum albumin (F-BSA) in liver endothelial cells. The study aimed to clarify the sequence and location of degradation steps. The findings may help distinguish between endosomal and lysosomal roles in protein turnover. The paper contributes by identifying distinct lysosomal populations involved in sequential degradation.
Purpose Of The Study:
This study aimed to determine the intracellular fate of formaldehyde-treated bovine serum albumin (F-BSA) in liver non-parenchymal cells. The researchers sought to identify which organelles are responsible for each stage of degradation. They focused on liver endothelial cells, which are known to internalize and process extracellular proteins. The study aimed to distinguish between endosomes and lysosomes in this process. The researchers also wanted to test the effects of Triton WR 1339 and mannan on organelle function. The goal was to determine if different lysosomal types handle different degradation phases. The study used both in vivo and in vitro approaches to achieve these objectives. The findings may clarify the compartmentalization of protein degradation in liver cells.
Main Methods:
The researchers injected formaldehyde-treated bovine serum albumin (F-BSA) into rats under different conditions. They used normal rats, Triton WR 1339-injected rats, and mannan-treated rats to alter organelle function. Organelle fractions were obtained through differential and isopycnic centrifugation in sucrose gradients. The fractions were analyzed using SDS-gel electrophoresis and fluorography to detect degradation products. In the second phase, purified organelles were isolated and incubated with radiolabeled F-BSA. Endosomes, transfer lysosomes, and accumulation lysosomes were tested separately for degradation capability. The presence of Triton WR 1339 and mannan was used to mark specific organelles. The researchers assessed the distribution of degradation products in sucrose gradients.
Main Results:
The degradation of F-BSA occurred in two distinct steps. The first step produced acid-precipitable radiolabeled compounds. These were distinct from acid-soluble radioactive molecules formed in the second step. Sucrose gradient analysis showed different distributions for the two types of degradation products. Endosomes isolated from the cells were found to be incapable of degrading F-BSA. Accumulation lysosomes, marked by mannan, contained hydrolases like arylsulfatase but lacked efficient proteolytic activity. Transfer lysosomes, identified in the study, were responsible for the second degradation step. The first degradation step likely occurred in a hybrid endosome-lysosome structure. These findings suggest a compartmentalized degradation pathway in liver non-parenchymal cells.
Conclusions:
The study suggests that F-BSA degradation occurs in two distinct organelles within liver non-parenchymal cells. The first step likely takes place in a hybrid endosome-lysosome structure. The second step occurs in transfer lysosomes, which are distinct from accumulation lysosomes. Endosomes themselves were not involved in degradation. Accumulation lysosomes, while rich in some hydrolases, lacked effective proteolytic machinery. The findings support a model of sequential degradation in different lysosomal compartments. The results align with the observed distribution of degradation products in sucrose gradients. The study provides evidence for compartmentalized protein degradation in liver endothelial cells.
Frequently Asked Questions
The study found that F-BSA degradation occurs in two distinct organelles: a hybrid endosome-lysosome and transfer lysosomes.
Endosomes, transfer lysosomes, and accumulation lysosomes were isolated and tested for degradation capability.
Triton WR 1339 and mannan were used to mark and isolate specific organelles involved in endocytic pathways.
Sucrose gradients were used to separate and analyze degradation products based on their density distributions.
The study observed distinct acid-precipitable and acid-soluble degradation products with different sucrose gradient distributions.
The authors suggest the first step occurs in a hybrid endosome-lysosome structure, not endosomes alone.
More Related Videos
08:38A Standardized Method for the Analysis of Liver Sinusoidal Endothelial Cells and Their Fenestrations by Scanning Electron Microscopy
Published on: April 30, 2015
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Related Concept Videos
Receptor-mediated Endocytosis
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Export of Misfolded Proteins out of the ER
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis II: Pathophysiology